References
- Berthou F L., Bardou L G., Flock H H. Measurement of 5α-androstan-3α-17β-diol and 5β-androstan-3α-17β-diol in the urine of healthy men and women. J Steroid Biochem 1971; 2: 141–145
- Deslypere J P., Wiers P W., Sayed A, et al. Urinary excretion of androgen metabolites, comparison with excretion of radioactive metabolites after injection of (4−14C)testosterone. Acta Endocrinol 1982; 96: 265–272
- Deslypere J P., Sayed A, Punjabi U, et al. Plasma 5α-androstane-3α,17β-diol and urinary 5α-androstane-3α,17β-diol glucuronide, parameters of peripheral androgen action: A comparative study. J Clin Endocrinol Metab 1982; 54: 386–391
- Griffin J E., Wilson J D. The syndrome of androgen resistance. N Engl J Med 1980; 302: 198–209
- Lee P A., Mazur T, Danish R, et al. Micropenis I. Criteria, etiologies and classification. Johns Hopkins Med J 1980; 146: 156–163
- Lischka A, Herkner K, Pollak A. Urinary androstanediols characterize the genital status in a male infant with growth hormone deficiency. Pediatr Res 1986; 20: 1161
- Lischka A. Molecular biology of androgen action in genital hypoplasia associated with congenital growth hormone deficiency: A “transitory androgen insensitivity syndrome”?. Arch Androl 1987; 18: 269–275
- Migeon C J., Brown T R., Fichman K R. Androgen insensitivity syndrome. The Intersex Child, N Josso. S. Karger, Basel 1981; 171–202
- Muller L, Philipou G. Quantification of 5α- and 5β-androstanediols in urine by gas chromatography-mass spectroscopy. Clin Chem 1987; 33: 256–260
- Penny R. Disorders of the testis. Clinical Pediatric and Adolescent Endocrinology, S A. Kaplan. Saunders, Philadelphia 1982; 300–326
- Thenot J P., Horning E C. MO-TMS derivation of human urinary steroids for GC-MS studies. Anal Letts 1972; 5: 21–26
- Zachman P, Prader A, Kind H P., et al. Testicular volume during adolescence. Cross sectional and longitudinal studies. Helv Paediatr Acta 1974; 29: 61–72